Abstract
Difficult asthma is defined as asthma that is not controlled despite treatment with <>800 ug budesonide or equivalent per day. Poor control is defined as the need for bronchodilators more than three times a week, school absence of more than five days a term, or one episode or more of wheezing each month. Common causes of poor response to treatment include; wrong diagnosis, inappropriate medications or improper inhalation technique, poor adherence to medications and co-morbidity. Steroid resistant asthma is uncommon and estimated to be 1 in 1000–10000 asthmatic patients. If there is no functional improvement to prednisolone 2 mg/kg/day for 2 weeks with adherence checked by measuring serum prednisoloneand cortisol levels, a fibreoptic bronchoscopic examination with bronchoalveolar lavage and large airway biopsy should be considered. Eosinophilic inflammation identified on the biopsy in a child who is unresponsive to prednisolone may benefit from alternative anti-inflammatory treatments such as cyclosporin. Neutrophilic infiltration in biopsy may benefitwith macrolide antibiotics, 5-lipogenase inhibitors or theophyllines.
Similar content being viewed by others
References
Lodha R, Puranik M, Kattal N, Kabra SK. Social and Economic Impact of Childhood Asthma.Indian Pediatr 2003; 40: 874–879.
Singh M, Kumar L, Ramanathan RMLP. Consensus guidelines on management of childhood asthma in India.Indian Pediatr 1999; 36: 157–165.
National Heart Lung and Blood Institute and World Health Organization. Global initiative for asthma. National Institute of Health, Bethesda. 1995 Publication No. 95-3659.
National Heart Lung and Blood Institute. Expert panel report 2. Guideline for the diagnosis and management of asthma. National Institute of Health, Bethesda HD, 1997 Publication No. 97-4051.
The British guideline on asthma management review and position statement.Thorax 1997; 52: S1-S21.
Chung KF, Godard P, Adelroth Eet al. Difficult/therapyresistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society.Eur Respir J 1999; 13: 1198–208.
Holt S, Suder A, Weatherall Met al. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis.BMJ 2001; 323: 253.
Silverman M. Childhood asthma and other wheezing disorders. London: Chapman and Hall, 1995.
Keeley D, Osman L. Dysfunctional breathing and asthma. It is important to tell the difference.BMJ 2001; 322: 1075–1076.
Fox GF, Everard ML, Marsh MJet al. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing.Arch Dis Child 1999; 80: 343–347.
Chavasse RJ, Bastian-Lee Y, Richter Het al. Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone.Arch Dis Child 2001; 85: 143–148.
Warner JO. Review of prescribed treatment for children with asthma in 1990.BMJ 1995; 311: 663–666.
Gibson NA, Ferguson AE, Aitchison TCet al. Compliance with inhaled asthma medication in preschool children.Thorax 1995; 50: 1274–1279.
Jonasson G, Carlsen KH, Blomqvist P. Clinical efficacy of lowdose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids.Eur Respir J 1998; 12: 1099–1104.
Wilson RG. Fabricated or induced illness in children. Munchausen by proxy comes of age.BMJ 2001; 323: 296–297.
Harding SM: Gastro-oesophageal reflux and asthma: Insight into the association.J Allergy Clin Immunol 1999; 104: 251–259.
Thomas EJ, Kumar R, Dasan JB, Kabra SK, Bal CS, Menon S, Malhothra A. Gastroesophageal reflux in asthmatic children not responding to asthma medication. A scintigraphic study in 126 patients with correlation between scintigraphic and clinical findings of reflux.Clin Imaging 2003; 27: 333–336.
Andze GO, Brandt ML St. Vil Det al. Diagnosis and treatment of gastro-esophageal reflux in 500 children with respiratory symptoms; the value of pH montoring.J Pediatr Surg 1991; 26: 295–299.
Gustafsson PM, Kjellman NI, Tibbing L. Bronchial asthma and acid reflux into the distal and proximal oesophagus.Arch Dis Child 1990; 65: 1255–1258.
Galmiche JP, Brandstatter G, Evreux M, Hentschel E, Kerstan E, Kratochvil Pet al. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.Gut 1988; 29: 675–681
Kelly DA. Do H2 receptor antagonists have a therapeutic role in childhood?J Pediatr Gasroenterol Nutr 1994; 19: 270–276.
Cucchiara S, Minella R, Iervolino Cet al. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.Arch Dis Child 1993; 69: 655–659
Kato S, Ebina K, Fujii Ket al. Effect of Omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four hour intragastric acidity.J Pediatr 1996; 128: 415–121.
Hassall E, Israel D, Shepherd Ret al. Omeprazole for treatment of chronic erosive oesophagitis in children; a multi center study of efficacy, safety, tolerability and dose requirements.J Pediatr 2000; 137: 800–807.
Tolia V, Ferry G, Gunasekaran T, Huang B, Keith R, Book L. Efficacy of lansoprazole in the treatment of gastro-esophageal reflux disease in children.J Pediatr Gastoenterol Nutr 2002 35; S308-S318.
Tolia V, Fitzgerald J, Hassall E, Huang B, Pilmer B, Kane R ffl. Safety of Lansoprazole in the treatment of gastro-esophageal reflux disease in children.J Pediatr Gastoenterol Nutr 2002; 35: S300-S307.
Tsao CH, Chen LC, Yeh KW, Huang JL. Concomitant chronic sinusitis treatment in children with mild asthma: the effect on bronchial hyperresponsiveness.Chest 2003; 123: 757–764.
Ranganathan SC, Payne DN, Jaffe Aet al. Difficult asthma: defining the problems.Pediatr Pulmonol 2001; 31: 114–1120.
Sulakvelidze I, Inman MD, Rerecich Tet al. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics.Eur Respir J 1998; 11: 821–827.
Nimmagadda SR, Szefler SJ, Spahn JDet al. Allergen exposure decreases glucocorticoids receptor binding affinity and steroid responsiveness in atopic asthmatics.Am J Respir Crit Care Med 1997; 155: 87–93.
Strachan DP, Carey IM. Home environment and severe asthma in adolescence: a population based case-control study.BMJ 1995; 311: 1053–106.
Custovic A, Woodcock A. On allergens and asthma (again): does exposure to allergens in homes exacerbate asthma?Clin Exp Allergy 2001; 31: 670–673.
Carter MC, Perzanowski MS, Raymond Aet al. Home intervention in the treatment of asthma among inner-city children.JAllergy Clin Immunol 2001; 108: 732–737.
Ratageri VH, Kabra SK, Dwivedi SN, Seth V. Factors associated with severe asthma.Indian Pediatr 2000; 37: 1072–1082.
Payne DN, Wilson NM, James Aet al. Evidence for different subgroups of difficult asthma in children.Thorax 2001; 56: 345–350.
Payne DNR, Adcock IM. Molecular mechanisms of corticosteroid resistance.Pediatr Respir Rev 2001; 2: 145–150.
Chapman KR. Asthma unresponsive to usual therapy. In FitzGerald JM, Ernst P, Boulet LP, Cbryne PM, eds.Evidence Based Asthma Management, London, BC Decker Inc, 2001; 291–305.
Payne D, McKenzie SA, Stacey Set al. Safety and ethics of bronchoscopy and endobronchial biopsy in difficult asthma.Arch Dis Child 2001; 84: 423–426
Coren ME, Rosenthal M, Bush A. The use of cyclosporin in corticosteroid dependent asthma.Arch Dis Child 1997; 77: 522–23.
McKenzie SA, Bush A. Difficult asthma in children.Arch Dis Child 2003; 88: 168–169
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kabra, S.K., Lodha, R. Management of unresponsive asthma. Indian J Pediatr 71, 729–732 (2004). https://doi.org/10.1007/BF02730664
Issue Date:
DOI: https://doi.org/10.1007/BF02730664